Allan D. Sniderman
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
-
- Lipid metabolism and disorders
Papers in
- Surgery 122
- Lipoproteins and Cardiovascular Health 97
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 92
- Co-authors
- Katherine Cianflone (34 shared papers)Michael Pencina (27 shared papers)Katherine Cianflone (16 shared papers)Ken Williams (19 shared papers)Curt D. Furberg (16 shared papers)Peter O. Kwiterovich (13 shared papers)Katherine Cianflone (17 shared papers)Ralph B. D’Agostino (8 shared papers)
- Journals
- The American Journal of Cardiology (18 papers)Journal of clinical lipidology (17 papers)Journal of Lipid Research (16 papers)Current Opinion in Lipidology (13 papers)Circulation (12 papers)
- Partner nations
- CanadaUnited StatesNetherlands
In The Last Decade
Allan D. Sniderman
287 papers receiving 15.9k citations
Allan D. Sniderman's Hit Papers
Peers
Comparison fields: 5 of 163
- Endocrinology, Diabetes and Metabolism 4.6k
- Cardiology and Cardiovascular Medicine 3.2k
- Surgery 5.8k
- Cancer Research 1.4k
- Nephrology 653
Countries citing papers authored by Allan D. Sniderman
This map shows the geographic impact of Allan D. Sniderman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan D. Sniderman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan D. Sniderman more than expected).
Fields of papers citing papers by Allan D. Sniderman
This network shows the impact of papers produced by Allan D. Sniderman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan D. Sniderman. The network helps show where Allan D. Sniderman may publish in the future.
Co-authors
The 25 scholars most cited alongside Allan D. Sniderman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 292 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Impact of left ventricular hypertrophy on survival in end-stage renal disease Hit paper breakdown → | 1989 | 642 |
| 2 | Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study Hit paper breakdown → | 2008 | 617 |
| 3 | Application of New Cholesterol Guidelines to a Population-Based Sample Hit paper breakdown → | 2014 | 467 |
| 4 | The Relation of Risk Factors to the Development of Atherosclerosis in Saphenous-Vein Bypass Grafts and the Progression of Disease in the Native Circulation Hit paper breakdown → | 1984 | 463 |
| 5 | A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk Hit paper breakdown → | 2011 | 443 |
| 6 | 2003 | 409 | |
| 7 | Apolipoprotein B Particles and Cardiovascular Disease Hit paper breakdown → | 2019 | 357 |
| 8 | Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease Hit paper breakdown → | 2015 | 280 |
| 9 | 1990 | 255 | |
| 10 | 2001 | 254 | |
| 11 | 1984 | 250 | |
| 12 | 1986 | 227 | |
| 13 | 1982 | 227 | |
| 14 | 2004 | 222 | |
| 15 | 1983 | 204 | |
| 16 | 2011 | 195 | |
| 17 | 1993 | 195 | |
| 18 | 2007 | 186 | |
| 19 | 1993 | 179 | |
| 20 | Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. | 1994 | 173 |
About Allan D. Sniderman
Allan D. Sniderman is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Epidemiology and Physiology, having authored 292 papers that have together received 16.6k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (97 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (92 papers), Adipose Tissue and Metabolism (24 papers), Lipid metabolism and disorders (24 papers), Cancer, Lipids, and Metabolism (24 papers), Adipokines, Inflammation, and Metabolic Diseases (23 papers), Cardiovascular Function and Risk Factors (16 papers) and Health Systems, Economic Evaluations, Quality of Life (16 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.6k citations), Cardiology and Cardiovascular Medicine (3.2k citations), Surgery (5.8k citations), Cancer Research (1.4k citations) and Nephrology (653 citations). Allan D. Sniderman has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Katherine Cianflone, Michael Pencina, Katherine Cianflone, Ken Williams, Curt D. Furberg, Peter O. Kwiterovich, Katherine Cianflone, Ralph B. D’Agostino, J. Silberberg and George Thanassoulis. Their work appears in journals such as The American Journal of Cardiology, Journal of clinical lipidology, Journal of Lipid Research, Current Opinion in Lipidology and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.